SCHEMBL21994504

SCHEMBL21994504

[CH2]C(F)(F)c1cccc(C)c1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 2/20 0.44
ATM Q13315 1/20 0.44
GABRA1 P14867 1/20 0.39
GABRB2 P47870 1/20 0.39
CYP1A2 P05177 1/20 0.35
CYP2A6 P11509 1/20 0.35
TSHR P16473 2/20 0.33
ACHE P22303 2/20 0.33
ALDH1A1 P00352 2/20 0.33
CA2 P00918 2/20 0.33
CA1 P00915 1/20 0.33
CA7 P43166 1/20 0.33
CA9 Q16790 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
MAPT P10636 2/20 0.32
KEAP1 Q14145 1/20 0.31
NFE2L2 Q16236 1/20 0.31
PDK2 Q15119 1/20 0.31
RAPGEF4 Q8WZA2 1/20 0.31
SCN8A Q9UQD0 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3821590 0.81 TRPA1 (0.48) TRPA1ATMGABRA1GABRB2CYP1A2
SCHEMBL30867018 0.81 TRPA1 (0.48) TRPA1ATMGABRA1GABRB2CYP1A2
SCHEMBL21958801 0.79 TRPA1 (0.46) TRPA1ATMGABRA1GABRB2CYP1A2
SCHEMBL22827235 0.79 TRPA1 (0.46) TRPA1ATMGABRA1GABRB2CYP1A2
SCHEMBL15957667 0.77 TRPA1 (0.50) TRPA1ATMGABRA1GABRB2CYP1A2
SCHEMBL5358414 0.77 TRPA1 (0.44) TRPA1ATMGABRA1GABRB2CYP1A2
SCHEMBL18957950 0.76 TRPA1 (0.43) TRPA1ATMGABRA1GABRB2CYP1A2
SCHEMBL26068785 0.76 TRPA1 (0.43) TRPA1ATMGABRA1GABRB2CYP1A2
SCHEMBL10022817 0.76 TRPA1 (0.43) TRPA1ATMGABRA1GABRB2CYP1A2
SCHEMBL27417963 0.75 TRPA1 (0.39) TRPA1ATMGABRA1GABRB2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230165252-A1 ACTIVE COMPOUND COMBINATIONS BAYER AKTIENGESELLSCHAFT (DE) 2023-06-01 US disclosed
US-20230054449-A1 PYRIDAZINE (THIO)AMIDES AS FUNGICIDAL COMPOUNDS BAYER AKTIENGESELLSCHAFT (DE) 2023-02-23 US disclosed
EP-3887362-A1 PYRIDAZINE (THIO)AMIDES AS FUNGICIDAL COMPOUNDS Bayer Aktiengesellschaft (DE) 2021-10-06 EP disclosed
WO-2020109391-A1 PYRIDAZINE (THIO)AMIDES AS FUNGICIDAL COMPOUNDS BAYER AKTIENGESELLSCHAFT (DE) 2020-06-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230165252-A1 ACTIVE COMPOUND COMBINATIONS CYP51A1, ERG28, BROX TRPA1 1897/4885ATM 3568/4885GABRA1 2869/4885
US-20230054449-A1 PYRIDAZINE (THIO)AMIDES AS FUNGICIDAL COMPOUNDS PNPO, TPMT, BLVRB TRPA1 1231/4885ATM 2089/4885GABRA1 2402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.